A-1331852 is a potent, selective Bcl-xL inhibitor. It affects the apoptosis signaling pathway by disrupting Bcl-xL/BIM complexes and promoting BAX/BAK activation, effectively inducing apoptosis and inhibiting tumor growth and fibrosis.
A-1331852 IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for A-1331852 Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.